Thermo Fisher Scientific to Showcase Anatomical Pathology Applications
|
By LabMedica International staff writers Posted on 12 Sep 2011 |
|
Image: The Cryostar NX70 Cryostat (Photo courtesy of Thermo Fisher Scientific).
Thermo Fisher Scientific (Runcorn, United Kingdom) will display its latest anatomical pathology solutions at the Institute of Biomedical Science (IBMS) Congress 2011 to be held at the International Convention Center (ICC) Birmingham from September 26-28, 2011.
The anatomical pathology solutions to be exhibited include the Thermo Scientific next generation STP 420ES tissue processor, the Cryostar NX70 cryostat, and SecureSette tissue embedding cassettes.
The latest STP 420ES tissue processor is suitable for high-throughput tissue processing. It enables faster turnaround times for same-day diagnosis and leaner workflows through operational flexibility. Using a dual-chamber design, which features rotational agitation that increases flow of traditional reagents by sevenfold to reduce processing times, the STP 420ES can process up to 420 cassettes per run. Holding 360 and 60 cassettes in the first and second chambers respectively, the second chamber allows independent processing of stat samples, as well as special or difficult tissues, without disrupting routine workflow or requiring the use of a second instrument.
The new CryoStar NX70 Cryostat offers better sectioning quality and increased user comfort. It accommodates a wide range of cryotomy applications for both clinical and research use. Its special features include rapid response temperature control and an innovative knife carrier feed to deliver precise section thickness and consistency.
The Thermo Scientific SecureSette tissue cassette enables lean workflow and enhances patient safety. Orientation is maintained throughout tissue processing and embedding, which means that the cassette is not opened until the sample is embedded in paraffin and ready for sectioning.
Quick and reproducible instrument set-up is simple with the CryoStar NX70’s intuitive LCD display and electronic touch-screen, together with joystick control. Fine adjustment specimen orientation on all axes enables fast and easy specimen alignment. The innovative temperature control system adjusts quickly to changes in settings, enabling rapid cooling, as well as consistent and precise temperature control. Three user-defined favorites enable frequently used temperature settings to be instantly recalled.
During the IBMS congress, Thermo Fisher will also demonstrate products from its immunohistochemistry (IHC) range, including the Thermo Scientific Autostainer and Quanto Reagents. These products offer rapid turnaround times and a flexible, total IHC workflow solution. In addition, PrintMate and SlideMate, the latest additions to Thermo Fisher's slide labeling and tracking product ranges will be presented.
Related Links:
Thermo Fisher Scientific
Institute of Biomedical Science
Institute of Biomedical Science Congress
The anatomical pathology solutions to be exhibited include the Thermo Scientific next generation STP 420ES tissue processor, the Cryostar NX70 cryostat, and SecureSette tissue embedding cassettes.
The latest STP 420ES tissue processor is suitable for high-throughput tissue processing. It enables faster turnaround times for same-day diagnosis and leaner workflows through operational flexibility. Using a dual-chamber design, which features rotational agitation that increases flow of traditional reagents by sevenfold to reduce processing times, the STP 420ES can process up to 420 cassettes per run. Holding 360 and 60 cassettes in the first and second chambers respectively, the second chamber allows independent processing of stat samples, as well as special or difficult tissues, without disrupting routine workflow or requiring the use of a second instrument.
The new CryoStar NX70 Cryostat offers better sectioning quality and increased user comfort. It accommodates a wide range of cryotomy applications for both clinical and research use. Its special features include rapid response temperature control and an innovative knife carrier feed to deliver precise section thickness and consistency.
The Thermo Scientific SecureSette tissue cassette enables lean workflow and enhances patient safety. Orientation is maintained throughout tissue processing and embedding, which means that the cassette is not opened until the sample is embedded in paraffin and ready for sectioning.
Quick and reproducible instrument set-up is simple with the CryoStar NX70’s intuitive LCD display and electronic touch-screen, together with joystick control. Fine adjustment specimen orientation on all axes enables fast and easy specimen alignment. The innovative temperature control system adjusts quickly to changes in settings, enabling rapid cooling, as well as consistent and precise temperature control. Three user-defined favorites enable frequently used temperature settings to be instantly recalled.
During the IBMS congress, Thermo Fisher will also demonstrate products from its immunohistochemistry (IHC) range, including the Thermo Scientific Autostainer and Quanto Reagents. These products offer rapid turnaround times and a flexible, total IHC workflow solution. In addition, PrintMate and SlideMate, the latest additions to Thermo Fisher's slide labeling and tracking product ranges will be presented.
Related Links:
Thermo Fisher Scientific
Institute of Biomedical Science
Institute of Biomedical Science Congress
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Silver Member
PCR Plates
Diamond Shell PCR Plates
Latest Technology News
- Robotic Technology Unveiled for Automated Diagnostic Blood Draws
- ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
- Aptamer Biosensor Technology to Transform Virus Detection
- AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
- AI-Generated Sensors Open New Paths for Early Cancer Detection
- Pioneering Blood Test Detects Lung Cancer Using Infrared Imaging
- AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
- Diagnostic Chip Monitors Chemotherapy Effectiveness for Brain Cancer
- Machine Learning Models Diagnose ALS Earlier Through Blood Biomarkers
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Industry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more